FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 344:1832-1838 June 14, 2001 Number 24 Next

	Full Text PDF Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Endogenous production of nitric oxide is vital for the decrease in pulmonary vascular resistance that normally occurs after birth. The precursor of nitric oxide is arginine, a urea-cycle intermediate. We hypothesized that low concentrations of arginine would correlate with the presence of persistent pulmonary hypertension in newborns and that the supply of this precursor would be affected by a functional polymorphism (the substitution of asparagine for threonine at position 1405 [T1405N]) in carbamoyl-phosphate synthetase, which controls the rate-limiting step of the urea cycle.

Methods Plasma concentrations of amino acids and genotypes of the carbamoyl-phosphate synthetase variants were determined in 65 near-term neonates with respiratory distress. Plasma nitric oxide metabolites were measured in a subgroup of 10 patients. The results in infants with pulmonary hypertension, as assessed by echocardiography, were compared with those in infants without pulmonary hypertension. The frequencies of the carbamoyl-phosphate synthetase genotypes in the study population were assessed for Hardy–Weinberg equilibrium.

Results As compared with infants without pulmonary hypertension, infants with pulmonary hypertension had lower mean (±SD) plasma concentrations of arginine (20.2±8.8 vs. 39.8±17.0 µmol per liter, P<0.001) and nitric oxide metabolites (18.8±12.7 vs. 47.2±11.2 µmol per liter, P=0.05). As compared with the general population, the infants in the study had a significantly skewed distribution of the genotypes for the carbamoyl-phosphate synthetase variants at position 1405 (P<0.005). None of the infants with pulmonary hypertension were homozygous for the T1405N polymorphism.

Conclusions Infants with persistent pulmonary hypertension have low plasma concentrations of arginine and nitric oxide metabolites. The simultaneous presence of diminished concentrations of precursors and breakdown products suggests that inadequate production of nitric oxide is involved in the pathogenesis of neonatal pulmonary hypertension. Our preliminary observations suggest that the genetically predetermined capacity of the urea cycle — in particular, the efficiency of carbamoyl-phosphate synthetase — may contribute to the availability of precursors for nitric oxide synthesis.

Source Information

From the Department of Pediatrics, Division of Neonatology (D.L.P., W.F.W.), the Department of Pathology (S.D.), the Department of Pediatrics, Division of Medical Genetics (J.L.H., A.B., N.S., M.L.S.), and the Department of Internal Medicine, Division of Pulmonary Medicine (B.W.C.), Vanderbilt University Medical Center, Nashville.

Address reprint requests to Dr. Summar at the Division of Medical Genetics, Vanderbilt University Medical Center, DD 2205 Medical Center North, Nashville, TN 37232, or at marshall.summar{at}mcmail.vanderbilt.edu.

Full Text of this Article

This article has been cited by other articles:

• Pare, G., Chasman, D. I., Parker, A. N., Zee, R. R.Y., Malarstig, A., Seedorf, U., Collins, R., Watkins, H., Hamsten, A., Miletich, J. P., Ridker, P. M (2009). Novel Associations of CPS1, MUT, NOX4, and DPEP1 With Plasma Homocysteine in a Healthy Population: A Genome-Wide Evaluation of 13 974 Participants in the Women's Genome Health Study. Circ Cardiovasc Genet 2: 142-150 [Abstract] [Full Text]  
• Barr, F. E., Tirona, R. G., Taylor, M. B., Rice, G., Arnold, J., Cunningham, G., Smith, H. A.B., Campbell, A., Canter, J. A., Christian, K. G., Drinkwater, D. C., Scholl, F., Kavanaugh-McHugh, A., Summar, M. L. (2007). Pharmacokinetics and safety of intravenously administered citrulline in children undergoing congenital heart surgery: Potential therapy for postoperative pulmonary hypertension. J. Thorac. Cardiovasc. Surg. 134: 319-326 [Abstract] [Full Text]  
• Lara, A. R., Erzurum, S. C. (2005). A Urinary Test for Pulmonary Arterial Hypertension?. Am. J. Respir. Crit. Care Med. 172: 262-263 [Full Text]  
• Task Force members, , Galie, N., Torbicki, A., Barst, R., Dartevelle, P., Haworth, S., Higenbottam, T., Olschewski, H., Peacock, A., Pietra, G., Rubin, L. J., Simonneau, G. (2004). Guidelines on diagnosis and treatment of pulmonary arterial hypertension: The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 25: 2243-2278 [Full Text]  
• Scaglia, F., Brunetti-Pierri, N., Kleppe, S., Marini, J., Carter, S., Garlick, P., Jahoor, F., O'Brien, W., Lee, B. (2004). Clinical Consequences of Urea Cycle Enzyme Deficiencies and Potential Links to Arginine and Nitric Oxide Metabolism. J. Nutr. 134: 2775S-2782S [Abstract] [Full Text]  
• Humbert, M., Sitbon, O., Simonneau, G. (2004). Treatment of Pulmonary Arterial Hypertension. NEJM 351: 1425-1436 [Full Text]  
• Wilkinson, D. L., Bertolo, R. F. P., Brunton, J. A., Shoveller, A. K., Pencharz, P. B., Ball, R. O. (2004). Arginine synthesis is regulated by dietary arginine intake in the enterally fed neonatal piglet. Am. J. Physiol. Endocrinol. Metab. 287: E454-E462 [Abstract] [Full Text]  
• Kallianpur, A. R., Hall, L. D., Yadav, M., Christman, B. W., Dittus, R. S., Haines, J. L., Parl, F. F., Summar, M. L. (2004). Increased Prevalence of the HFE C282Y Hemochromatosis Allele in Women with Breast Cancer. Cancer Epidemiol. Biomarkers Prev. 13: 205-212 [Abstract] [Full Text]  
• Summar, M. L., Gainer, J. V., Pretorius, M., Malave, H., Harris, S., Hall, L. D., Weisberg, A., Vaughan, D. E., Christman, B. W., Brown, N. J. (2004). Relationship Between Carbamoyl-Phosphate Synthetase Genotype and Systemic Vascular Function. Hypertension 43: 186-191 [Abstract] [Full Text]  
• Cooke, J. P. (2003). A Novel Mechanism for Pulmonary Arterial Hypertension?. Circulation 108: 1420-1421 [Full Text]  
• Morris, C. R., Morris, S. M. Jr., Hagar, W., van Warmerdam, J., Claster, S., Kepka-Lenhart, D., Machado, L., Kuypers, F. A., Vichinsky, E. P. (2003). Arginine Therapy: A New Treatment for Pulmonary Hypertension in Sickle Cell Disease?. Am. J. Respir. Crit. Care Med. 168: 63-69 [Abstract] [Full Text]  
• Vosatka, R. J. (2002). Persistent Pulmonary Hypertension of the Newborn. NEJM 346: 864-864 [Full Text]